Key Points
- Professor Peter Hindmarsh was barred from treating patients by University College London Hospitals in March 2023.
- His evidence supported the prosecution’s claim that two babies in the Lucy Letby case had been poisoned with insulin.
- The General Medical Council had investigated concerns about his clinical work and sought restrictions on his practice.
- A medical practitioners tribunal declined to suspend his registration in April 2023 but required direct supervision for patient treatment.
- The jury was not told during Letby’s trial that Professor Hindmarsh had been excluded from clinical practice.
Manchester (East London Times) November 18, 2026 – Professor Peter Hindmarsh, the paediatric endocrinologist whose evidence helped prosecutors argue that Lucy Letby poisoned two babies with insulin, was barred from treating patients during her trial after University College London Hospitals raised concerns about patient safety. The restriction was imposed in March 2023, about five months before the trial concluded at Manchester Crown Court. The jury was not informed that Professor Hindmarsh had been removed from clinical duties or that the General Medical Council had sought action over his fitness to practise.
Why was Professor Peter Hindmarsh barred from treating patients?
As reported by The Guardian, University College London Hospitals told the General Medical Council that it could not accept the level of risk Professor Hindmarsh appeared to pose to children and young people, even with close supervision. The concerns included advice involving insulin and diabetes.
The hospital reportedly identified three cases involving Professor Hindmarsh. Two involved insulin-related advice to children or their families. In one case, a child experienced diabetic ketoacidosis, although the available account did not establish whether the episode occurred at the same time as the advice attributed to him.
The Guardian also reported concerns that Professor Hindmarsh had focused excessively on rare causes of hypoglycaemia and diabetes. University College London Hospitals therefore excluded him from clinical practice while the regulatory investigation continued.
What did the medical tribunal decide?
The General Medical Council sought to suspend Professor Hindmarsh’s registration. In April 2023, however, an independent three-person medical practitioners tribunal decided that suspension would be disproportionate.
The tribunal required Professor Hindmarsh to work under direct supervision when treating patients. It also allowed him to continue non-clinical work, including acting as an expert witness. The order had limited practical effect on his clinical duties because University College London Hospitals had already barred him from treating patients.
The tribunal found that the cases identified by the hospital raised patient-safety concerns. It said it could not determine whether earlier restrictions had been formally breached.
How did Professor Hindmarsh’s evidence feature in the Lucy Letby trial?
Professor Hindmarsh gave evidence for the prosecution about hormone results involving two babies at the Countess of Chester Hospital. He told the court that the results were consistent with insulin poisoning, probably caused by insulin being introduced into intravenous fluid bags.
The prosecution presented the insulin evidence as central to its case against Lucy Letby, who was convicted of murdering seven babies and attempting to murder seven others. Reports said the defence knew that the General Medical Council was investigating Professor Hindmarsh but was not told during the trial that University College London Hospitals had barred him from treating patients or that the tribunal had imposed direct-supervision requirements.
The reported disclosures do not, by themselves, establish whether Professor Hindmarsh’s clinical restrictions affected the reliability or admissibility of his trial evidence. Any such issue would require consideration by the courts and relevant legal representatives.
What is the background to the development?
Lucy Letby was tried at Manchester Crown Court over allegations involving babies treated at the Countess of Chester Hospital. Professor Hindmarsh was presented by prosecutors as a leading authority on paediatric insulin and hormone disorders. His evidence supported the argument that abnormal insulin results were the result of deliberate poisoning rather than natural illness. The General Medical Council investigation and the hospital’s restrictions concerned his clinical practice, while his expert-witness work was expressly permitted by the medical tribunal.
What could the disclosure mean for the case?
The disclosure could prompt renewed scrutiny of whether the prosecution and defence were given all material information about Professor Hindmarsh before the jury considered his evidence. It may also lead legal representatives to examine the tribunal’s findings, the hospital’s patient-safety concerns and the timing of the restrictions.
However, the available reports do not show that a court has ruled that Professor Hindmarsh’s evidence was invalid or that Lucy Letby’s convictions have been overturned. The practical effect will depend on any application by Letby’s legal team, decisions by the Court of Appeal and further findings about what information was known to the prosecution and defence during the trial.
